Safety and tolerability of sitagliptin in patients with type 2 diabetes: a pooled analysis

by Davies Michael J, Musser Bret, Swern Arlene S, Round Elizabeth, Williams-Herman Debora, Stein Peter P, Kaufman Keith D, Amatruda John M
Published 2008-10-01

KarMMa-RW: comparison of idecabtagene vicleucel with real-world outcomes in relapsed and refractory multiple myeloma.

by Jagannath, Sundar, Lin, Yi, Goldschmidt, Hartmut, Reece, Donna, Nooka, Ajay, Senin, Alicia, Rodriguez-Otero, Paula, Powles, Ray, Matsue, Kosei, Shah, Nina, Anderson, Larry D, Streetly, Matthew, Wilson, Kimberly, Le, Hoa Van, Swern, Arlene S, Agarwal, Amit, Siegel, David S
Published 2021

Real-world clinical experience in the Connect® chronic lymphocytic leukaemia registry: a prospective cohort study of 1494 patients across 199 US centres.

by Mato, Anthony, Nabhan, Chadi, Kay, Neil E, Weiss, Mark A, Lamanna, Nicole, Kipps, Thomas J, Grinblatt, David L, Flinn, Ian W, Kozloff, Mark F, Flowers, Christopher R, Farber, Charles M, Kiselev, Pavel, Swern, Arlene S, Sullivan, Kristen, Flick, E Dawn, Sharman, Jeff P
Published 2016